Sarah McBane

Sarah McBane

Auto-generated profile, based on publicly available information

Sarah McBane

Department of Clinical Pharmacy Practice University of California Irvine School of Pharmacy and Pharmaceutical Sciences Irvine California USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2024 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
DKDenise M. Kolanczyk
Denise M. Kolanczyk
JMJessica R. Merlo
Jessica R. Merlo
BBBridget Bradley
Bridget Bradley
AFAlexander H. Flannery
Alexander H. Flannery
CGCaitlin M. Gibson
Caitlin M. Gibson
KTKrisy‐Ann Thornby
Krisy‐Ann Thornby

1 May 2023 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
SMSarah McBane
Sarah McBane
PAPrasannaraddi Alavandi
Prasannaraddi Alavandi
SASheila Allen
Sheila Allen
ABAngela Bingham
Angela Bingham
YDYen Dang
Yen Dang
ASAmy L. Seybert
Amy L. Seybert
Simulation, an educational, assessment, and research technique used to mimic real‐world situations, is increasingly used in pharmacy education. The most‐used simulation methods include high‐fidelity simulation (HFS), low‐fidelity simulation (LFS), standardized patients, and game‐based simulation. A common element of simulation is its ability to offer learners the chance to practice a skill or acquire knowledge in a safe and accessible space. Simulation methods differ in key aspects, including cost and other resource investment as well as ideal venue for use in education. HFS provides a more realistic simulation environment than LFS but is typically more expensive. Standardized patients offer learners the opportunity to engage with a live person but may elicit greater variability in responses to learners' input than HFS. Computer‐based simulation uses technology to supply a wide variety of learning opportunities; however, it may require the use of proprietary software and devices. Despite widespread use, literature describing learning outcomes of simulation in pharmacy education is limited. Some existing reports with positive findings have focused on learner satisfaction with or perceived benefit of simulation activities. The few existing publications summarizing changes in skills or knowledge demonstrate a positive impact. Simulation is a promising modality for educating pharmacy students and residents; however, more data summarizing the benefit of learning outcomes are needed.

3 April 2014 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
EHElizabeth Kelly Hester
Elizabeth Kelly Hester
SMSarah E. McBane
Sarah E. McBane
MBMichael B. Bottorff
Michael B. Bottorff
TCTristan A. Carnes
Tristan A. Carnes
KDKamila Dell
Kamila Dell
TTToby C. Trujillo
Toby C. Trujillo

25 November 2022 in Journal of Pharmacy Practice
Verified
Journal Article
Closed access
KBKylie N. Barnes
Kylie N. Barnes
LLLauren D. Leader
Lauren D. Leader
NCNicole Cieri-Hutcherson
Nicole Cieri-Hutcherson
JKJulie Kelsey
Julie Kelsey
MHMary F. Hebert
Mary F. Hebert
SMSarah McBane
Sarah McBane
Complications throughout the peripartum period may be caused by preexisting conditions or pregnancy-induced conditions and may alter pharmacotherapy management. Pharmacotherapy management during late pregnancy and delivery requires careful consideration due to changing hormones, hemodynamic status, and pharmacokinetics, and concerns for potential maternal and/or fetal morbidity. Increased maternal and fetal monitoring are often required and may lead to therapy changes. Pharmacists, as key members of the interprofessional team, can contribute essential perspective to the management of postpartum pharmacotherapy through assessment and recommendation of appropriate and judicious use of medications.

27 April 2025 in Journal of the American Pharmacists Association
Verified
Journal Article
Open access
JRJordan M. Rowe
Jordan M. Rowe
SMSarah McBane
Sarah McBane
JWJackson T. Warner
Jackson T. Warner
LCLauren Cirrincione
Lauren Cirrincione
Transgender and gender-diverse (TGD) people may self-administer injectable estradiol or testosterone therapy for gender-affirming hormone therapy (GAHT). Knowledge about injection-related safety and injection adherence for TGD people remains to be determined. To determine the types of injection-related safety issues and medication adherence issues reported in the literature for TGD people on injectable GAHT. Our secondary objective was to identify opportunities for pharmacists to enhance the self-injection experience for TGD people on injectable GAHT. We examined the literature to determine the types of issues TGD people experience when prescribed injectable GAHT. We searched for English language publications in PubMed and Google Scholar from inception to 5 August 2024 (e.g., "transgender," "nonbinary," "self-inject*," "estrogens," "testosterone") and included original research publications that assessed one of three injection-related domains: Safety (injection site-related reactions or pain, psychological safety around injections), injection-related medication administration (individual self-injection practices and preferences including family or caregiver support administering injections, access to appropriate injection supplies, continuation of injections, patient-reported comfort) and teaching and assessment of injection practices by a pharmacist or other health care provider (clinic- or pharmacy-based injection counseling or follow-up assessments). We excluded articles that did not describe whether GAHT was self-injected and publications about long-acting injectable testosterone undecanoate, as trained providers administer this medication. Seven publications discussed at least one of the three injection-related domains. Investigators used various methods for assessing these elements across publications. Although self-injected GAHT was well-tolerated overall, most publications reported injection site reactions that were managed while continuing self-injected GAHT. Gaps included comprehensive teaching and assessment of individual self-injection practices long-term. Based on the types of injection-related challenges identified, pharmacists, as one of the most accessible health care providers in the United States, are well-positioned to intervene and improve the experience of patients using injectable GAHT.

12 August 2025 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Closed access
SSSharon See
Sharon See
BNBranden D. Nemecek
Branden D. Nemecek
SASheila M. Allen
Sheila M. Allen
IAIjeoma Agada
Ijeoma Agada
SBShubha Bhat
Shubha Bhat
RWRaegan T. Willoughby
Raegan T. Willoughby